Edgewise Therapeutics Ownership | Who Owns Edgewise Therapeutics?

Overview Forecast RevenueFinancials Chart

Edgewise Therapeutics Ownership Summary

Edgewise Therapeutics is owned by 116.05% institutional investors, 0.46% insiders. Orbimed advisors is the largest institutional shareholder, holding 17.15% of EWTX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.67% of its assets in Edgewise Therapeutics shares.

EWTX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Edgewise Therapeutics	116.05%	0.46%	-16.51%
Sector	Healthcare Stocks	46.80%	8.14%	45.06%
Industry	Biotech Stocks	44.70%	7.99%	47.31%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Orbimed advisors	15.02M	17.15%	$270.54M
Ra capital management	8.91M	10.17%	$160.45M
Novo	6.34M	7.25%	$114.26M
Blackrock	6.02M	6.87%	$108.34M
Baker bros. advisors lp	5.84M	6.67%	$105.18M
Fmr	4.78M	5.46%	$86.10M
Vanguard group	4.51M	5.15%	$81.19M
Frazier life sciences management	3.73M	4.26%	$67.20M
Cormorant asset management, lp	3.01M	3.43%	$54.15M
Deerfield management company, l.p. (series c)	2.87M	3.28%	$51.77M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
New leaf venture partners	1.55M	34.03%	$27.98M
Novo	6.34M	5.73%	$114.26M
Orbimed advisors	15.02M	5.38%	$270.54M
Tcg crossover management	2.27M	4.27%	$40.93M
Frazier life sciences management	3.73M	3.14%	$67.20M
Cormorant asset management, lp	3.01M	3.13%	$54.15M
Opaleye management	580.00K	2.39%	$10.45M
Ra capital management	8.91M	2.12%	$160.45M
Vr adviser	1.82M	2.09%	$32.75M
Bioimpact capital	740.66K	2.07%	$13.34M

Top Buyers

Holder	Shares	% Assets	Change
Novo	6.34M	5.73%	6.34M
Bellevue group	1.43M	0.42%	1.43M
Blackrock	6.02M	0.00%	848.71K
Janus henderson group	2.61M	0.03%	801.99K
Millennium management	1.15M	0.01%	613.25K

Top Sellers

Holder	Shares	% Assets	Change
Viking global investors lp	1.48M	0.10%	-1.86M
Fmr	4.78M	0.01%	-1.59M
Balyasny asset management	-	-	-528.59K
Perceptive advisors	1.86M	0.79%	-463.23K
Exoduspoint capital management, lp	-	-	-268.14K

New Positions

Holder	Shares	% Assets	Change	Value
Bellevue group	1.43M	0.42%	1.43M	$25.74M
Sofinnova investments	475.69K	0.45%	475.69K	$8.57M
Stempoint capital lp	271.06K	1.43%	271.06K	$4.88M
Polar asset management partners	187.50K	0.07%	187.50K	$3.38M
Adage capital partners gp	49.60K	0.00%	49.60K	$893.24K

Sold Out

Holder	Change
Pnc financial services group	-4.00
Creekmur asset management	-8.00
Nelson, van denburg & campbell wealth management group	-8.00
Allworth financial lp	-45.00
Comerica bank	-57.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2024	141	9.30%	101,619,838	10.90%	116	1.06%	91	1.11%	29	3.57%
Mar 31, 2024	129	9.32%	91,633,567	15.05%	104	0.67%	90	11.11%	28	40.00%
Dec 31, 2023	118	37.21%	79,648,503	16.42%	124	1.08%	81	65.31%	20	17.65%
Sep 30, 2023	86	-10.42%	68,414,835	-1.53%	107	0.90%	49	-3.92%	17	-26.09%
Jun 30, 2023	96	10.34%	69,476,308	4.55%	109	0.99%	51	34.21%	23	-11.54%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	2.52M	2.67%	-12.28K
iShares Russell 2000 ETF	1.87M	1.97%	-4.20K
BB Biotech AG Ord	1.43M	1.52%	-
Fidelity Small Cap Growth	983.35K	1.05%	-284.60K
Vanguard Institutional Extnd Mkt Idx Tr	878.21K	0.94%	-206.47K
American Century U.S. Small Cap Growth	805.79K	0.86%	122.16K
American Century Small Cap Growth Inv	805.79K	0.86%	122.16K
Fidelity Small Cap Index	743.23K	0.79%	-19.20K
Artisan International Small-Mid Investor	648.81K	0.69%	648.81K
Artisan Non-U.S. Small-Mid Growth Comp	648.81K	0.69%	648.81K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Sep 20, 2024	Russell Alan J	Chief Scientific Officer	Sell	$24.05K
Sep 20, 2024	Russell Alan J	Chief Scientific Officer	Sell	$2.10M
Sep 23, 2024	MOORE JOHN R	General Counsel	Sell	$578.06K
Sep 20, 2024	MOORE JOHN R	General Counsel	Sell	$1.42M
Sep 20, 2024	Donovan Joanne M.	CMO	Sell	$202.60K

Insider Transactions Trends

Date	Buy	Sell
2024 Q3	-	10
2024 Q2	-	6
2024 Q1	2	7
2023 Q4	1	2
2023 Q3	-	-

EWTX Ownership FAQ

Who Owns Edgewise Therapeutics?

Edgewise Therapeutics shareholders are primarily institutional investors at 116.05%, followed by 0.46% insiders and -16.51% retail investors. The average institutional ownership in Edgewise Therapeutics's industry, Biotech Stocks , is 44.70%, which Edgewise Therapeutics exceeds.

Who owns the most shares of Edgewise Therapeutics?

Edgewise Therapeutics’s largest shareholders are Orbimed advisors (15.02M shares, 17.15%), Ra capital management (8.91M shares, 10.17%), and Novo (6.34M shares, 7.25%). Together, they hold 34.57% of Edgewise Therapeutics’s total shares outstanding.

Does Blackrock own Edgewise Therapeutics?

Yes, BlackRock owns 6.87% of Edgewise Therapeutics, totaling 6.02M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 108.34M$. In the last quarter, BlackRock increased its holdings by 848.7K shares, a 16.43% change.

Who is Edgewise Therapeutics’s biggest shareholder by percentage of total assets invested?

New leaf venture partners is Edgewise Therapeutics’s biggest shareholder by percentage of total assets invested, with 34.03% of its assets in 1.55M Edgewise Therapeutics shares, valued at 27.98M$.

Who is the top mutual fund holder of Edgewise Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Edgewise Therapeutics shares, with 2.67% of its total shares outstanding invested in 2.52M Edgewise Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools